NASDAQ: TARSTarsus Pharmaceuticals Inc Stock Ownership - Who owns Tarsus Pharmaceuticals?
Insider buying vs selling
Have Tarsus Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William J. Phd Link | Director | 2025-09-08 | 27,116 | $57.00 | $1.55MSell |
| Bobak R. Azamian | PresidentCEO and Board Chair | 2025-08-11 | 6,000 | $50.00 | $300.00kSell |
| Jeffrey S. Farrow | Chief Financial Officer and Chief Strategy Officer | 2025-06-17 | 13,608 | $40.42 | $550.04kSell |
| Elizabeth Yeu Lin | Chief Medical Officer | 2025-06-16 | 1,006 | $41.08 | $41.33kSell |
| Aziz Mottiwala | Chief Commercial Officer | 2025-06-09 | 17,500 | $43.76 | $765.80kSell |
| Bobak R. Azamian | PresidentCEO and Board Chair | 2025-03-24 | 6,000 | $50.00 | $300.00kSell |
| Seshadri Neervannan | Chief Operating Officer | 2025-03-20 | 2,435 | $50.11 | $122.02kSell |
| Bryan Wahl | General Counsel | 2025-03-20 | 3,084 | $50.11 | $154.54kSell |
| Jeffrey S. Farrow | Chief Financial Officer and Chief Strategy Officer | 2025-03-20 | 1,186 | $50.11 | $59.43kSell |
| Dianne C. Whitfield | Chief Human Resources Officer | 2025-03-20 | 2,137 | $50.11 | $107.09kSell |
TARS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TARS insiders and whales buy or sell their stock.
TARS Shareholders
What type of owners hold Tarsus Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vivo Capital IX LLC | 13.54% | 5,714,036 | $282.04M | Insider |
| Blackrock Inc | 8.98% | 3,792,185 | $187.18M | Institution |
| Rtw Investments LP | 7.37% | 3,111,680 | $153.59M | Institution |
| Paradigm Biocapital Advisors LP | 7.05% | 2,976,099 | $146.90M | Institution |
| Jennison Associates LLC | 5.85% | 2,467,998 | $121.82M | Institution |
| Tang Capital Management LLC | 5.82% | 2,454,797 | $121.17M | Institution |
| Vanguard Group Inc | 5.44% | 2,297,354 | $113.40M | Institution |
| Morgan Stanley | 4.87% | 2,055,718 | $101.47M | Institution |
| Rtw Investments LP | 4.77% | 2,013,601 | $99.39M | Insider |
| Horowitz Limited Partnership VIII | 4.71% | 1,987,105 | $98.08M | Insider |
TARS vs Biotech Stocks
Tarsus Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.